Evidence map›Paper›PMID 41109928›Full record

ArticleOncogene2025

ZDHHC20-mediated S-palmitoylation of KAP1/TRIM28 promotes DNA damage repair.

Zhuang Liu, Han Wang, Yamei Han, Yang Chen, Youyou Wang, Siyue Zhang, Yaqi Mo, Chuanjie Wang, Mingming Xiao, Bo Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhuang Liu *Department of Biochemistry and Molecular Biology, The Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Han Wang *Chongqing Key Laboratory of Intelligent Oncology for Breast Cancer, Chongqing University Cancer Hospital and Chongqing University School of Medicine, Chongqing, China.
Yamei Han *Department of Biochemistry and Molecular Biology, The Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Yang ChenDepartment of Biochemistry and Molecular Biology, The Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Youyou WangDepartment of Biochemistry and Molecular Biology, The Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Siyue ZhangDepartment of Biochemistry and Molecular Biology, The Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Yaqi MoChongqing Key Laboratory of Intelligent Oncology for Breast Cancer, Chongqing University Cancer Hospital and Chongqing University School of Medicine, Chongqing, China.
Chuanjie WangChongqing Key Laboratory of Intelligent Oncology for Breast Cancer, Chongqing University Cancer Hospital and Chongqing University School of Medicine, Chongqing, China.
Mingming XiaoDepartment of Biochemistry and Molecular Biology, The Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. xiaomingming@fudanpci.org.ORCID 0000-0003-0862-2501
Bo XuDepartment of Biochemistry and Molecular Biology, The Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. xubo731@cqu.edu.cn.ORCID 0000-0001-8693-3060

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82003237National Natural Science Foundation of China (National Science Foundation of China) 82272754National Natural Science Foundation of China (National Science Foundation of China) 82503164
6 · The paper itself

Abstract

S-palmitoylation mediated by the zinc finger aspartate-histidine-histidine-cysteine (ZDHHC) protein acyltransferases (PATs) modulates protein localization, stability, interactions and signal transduction. In this study, we screened the 23 ZDHHC family members and identified ZDHHC20 as one of the major PATs involved in the DNA damage response (DDR). Inhibition of ZDHHC20 expression impaired cellular DNA damage repair capabilities. Meanwhile, data from ZDHHC20 knock-out mice, human tumor cell lines and xenograft tumor models showed that knock-out of ZDHHC20 significantly enhanced radiosensitivity. Using palmitoylation label-free quantitative proteomics, we found that over 600 proteins were palmitoylated in a ZDHHC20-dependent manner. Via the acyl-biotin exchange (ABE) assay, we revealed that KRAB-associated protein 1 (KAP1), also known as tripartite motif-containing protein 28 (Trim28), was palmitoylated at cysteine 232 by ZDHHC20. Notably, ZDHHC20-dependent KAP1 palmitoylation increased the chromatin binding of phosphorylated KAP1, which facilitated chromatin accessibility and subsequent recruitment of the DDR components BRCA1 and 53BP1. Further, we demonstrated that Ataxia-Telangiectasia Mutated (ATM)-dependent phosphorylation of ZDHHC20 at serine 339 increased KAP1 palmitoylation. Taken together, our findings elucidate the role and mechanism of the ATM-ZDHHC20-KAP1 axis in the DDR and provide a novel sensitizing strategy for radiotherapy and chemotherapy.

Indexed as

AcyltransferasesDNA DamageDNA RepairTripartite Motif-Containing Protein 28AnimalsCell Line, TumorHumansLipoylationMiceMice, KnockoutRadiation ToleranceAcyltransferasesTRIM28 protein, humanTripartite Motif-Containing Protein 28

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.